Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
2,465,693
-
Share change
-
-681,986
-
Total reported value
-
$15,138,000
-
Price per share
-
$6.14
-
Number of holders
-
12
-
Value change
-
-$3,893,771
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q3 2017
As of 30 Sep 2017,
AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,465,693 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, NEA Management Company, LLC, DEERFIELD MANAGEMENT CO, VHCP Management II, LLC, Vivo Capital, LLC, Hikari Power Ltd, MILLENNIUM MANAGEMENT LLC, BANK OF MONTREAL /CAN/, MORGAN STANLEY, and HUNTINGTON NATIONAL BANK.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.